135 related articles for article (PubMed ID: 38174569)
1. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE; Shoamanesh A; Xu L; Heenan L; Saad F; Colorado P; Chen CH; Lemmens R; De Marchis GM; Caso V; Masjuan J; Hirano T; Milanov I; Campbell BCV; Mas JL; Connolly SJ; Mundl H; Hart RG;
Stroke; 2024 Feb; 55(2):392-402. PubMed ID: 38174569
[TBL] [Abstract][Full Text] [Related]
2. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Shoamanesh A; Mundl H; Smith EE; Masjuan J; Milanov I; Hirano T; Agafina A; Campbell B; Caso V; Mas JL; Dong Q; Turcani P; Christensen H; Ferro JM; Veltkamp R; Mikulik R; De Marchis GM; Robinson T; Lemmens R; Stepien A; Greisenegger S; Roine R; Csiba L; Khatri P; Coutinho J; Lindgren AG; Demchuk AM; Colorado P; Kirsch B; Neumann C; Heenan L; Xu L; Connolly SJ; Hart RG;
Lancet; 2022 Sep; 400(10357):997-1007. PubMed ID: 36063821
[TBL] [Abstract][Full Text] [Related]
3. Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial.
Balali P; Hart RG; Smith EE; Saad F; Colorado P; Lemmens R; De Marchis GM; Caso V; Xu L; Heenan L; Connolly SJ; Mundl H; Shoamanesh A
Int J Stroke; 2024 Jun; 19(5):526-535. PubMed ID: 37950392
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Rao SV; Kirsch B; Bhatt DL; Budaj A; Coppolecchia R; Eikelboom J; James SK; Jones WS; Merkely B; Keller L; Hermanides RS; Campo G; Ferreiro JL; Shibasaki T; Mundl H; Alexander JH;
Circulation; 2022 Oct; 146(16):1196-1206. PubMed ID: 36030390
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.
Sharma M; Molina CA; Toyoda K; Bereczki D; Bangdiwala SI; Kasner SE; Lutsep HL; Tsivgoulis G; Ntaios G; Czlonkowska A; Shuaib A; Amarenco P; Endres M; Yoon BW; Tanne D; Toni D; Yperzeele L; von Weitzel-Mudersbach P; Sampaio Silva G; Avezum A; Dawson J; Strbian D; Tatlisumak T; Eckstein J; Ameriso SF; Weber JR; Sandset EC; Goar Pogosova N; Lavados PM; Arauz A; Gailani D; Diener HC; Bernstein RA; Cordonnier C; Kahl A; Abelian G; Donovan M; Pachai C; Li D; Hankey GJ
Lancet Neurol; 2024 Jan; 23(1):46-59. PubMed ID: 38101902
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.
Chen CH; Shoamanesh A; Colorado P; Saad F; Lemmens R; De Marchis GM; Caso V; Xu L; Heenan L; Masjuan J; Christensen H; Connolly SJ; Khatri P; Mundl H; Hart RG; Smith EE
Stroke; 2024 Jun; 55(6):1477-1488. PubMed ID: 38690666
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
Sharma M; Smith EE; Pearce LA; Perera KS; Kasner SE; Yoon BW; Ameriso SF; Puig J; Damgaard D; Fiebach JB; Muir KW; Veltkamp RC; Toni DS; Shamalov N; Gagliardi RJ; Mikulik R; Engelter ST; Bereczki D; O'Donnell MJ; Saad F; Shoamanesh A; Berkowitz SD; Mundl H; Hart RG;
Int J Stroke; 2022 Aug; 17(7):799-805. PubMed ID: 34791941
[TBL] [Abstract][Full Text] [Related]
8. Asundexian: an oral small molecule factor XIa inhibitor for the treatment of thrombotic disorders.
D'Allesandro N; Cave B; Hough A
Future Cardiol; 2023 Aug; 19(10):477-486. PubMed ID: 37830334
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
Sharma M; Hart RG; Smith EE; Bosch J; Eikelboom JW; Connolly SJ; Dyal L; Reeh KW; Casanova A; Diaz R; Lopez-Jaramillo P; Ertl G; Störk S; Dagenais GR; Lonn EM; Ryden L; Tonkin AM; Varigos JD; Bhatt DL; Branch KRH; Probstfield JL; Kim JH; O'Donnell M; Vinereanu D; A A Fox K; Liang Y; Liu L; Zhu J; Pogosova N; Maggioni AP; Avezum A; Piegas LS; Keltai K; Keltai M; Berkowitz SD; Yusuf S
Stroke; 2020 Oct; 51(10):2901-2909. PubMed ID: 32951537
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke.
Butcher KS; Ng K; Sheridan P; Field TS; Coutts SB; Siddiqui M; Gioia LC; Buck B; Hill MD; Miller J; Klahr AC; Sivakumar L; Benavente OR; Hart RG; Sharma M
Stroke; 2020 Apr; 51(4):1190-1198. PubMed ID: 32098609
[TBL] [Abstract][Full Text] [Related]
11. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
[TBL] [Abstract][Full Text] [Related]
12. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP; Caso V; Connolly SJ; Fox KAA; Oldgren J; Jones WS; Gorog DA; Durdil V; Viethen T; Neumann C; Mundl H; Patel MR;
Lancet; 2022 Apr; 399(10333):1383-1390. PubMed ID: 35385695
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial.
Sharma M; Smith EE; Pearce LA; Shoamanesh A; Perera KS; Coutts SB; Damgaard D; Ameriso SF; Rha JH; Modrau B; Yoon BW; Romano M; Messé SR; Barlinn J; Lambeck J; Saad F; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
Stroke; 2022 Jan; 53(1):45-52. PubMed ID: 34538089
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease.
Prabhakaran S; Liebeskind DS; Cotsonis G; Nizam A; Feldmann E; Sangha RS; Campo-Bustillo I; Romano JG;
Stroke; 2021 Jun; 52(6):1961-1966. PubMed ID: 33866818
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC;
Stroke; 2020 Dec; 51(12):3504-3513. PubMed ID: 33198608
[TBL] [Abstract][Full Text] [Related]
16. Large subcortical infarcts: clinical features, risk factors, and long-term prognosis compared with cortical and small deep infarcts.
Halkes PH; Kappelle LJ; van Gijn J; van Wijk I; Koudstaal PJ; Algra A
Stroke; 2006 Jul; 37(7):1828-32. PubMed ID: 16741175
[TBL] [Abstract][Full Text] [Related]
17. Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.
Wilson LK; Pearce LA; Arauz A; Anderson DC; Tapia J; Bazan C; Benavente OR; Field TS;
Int J Stroke; 2016 Jun; 11(4):412-9. PubMed ID: 26956031
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.
Sharma M; Molina CA; Toyoda K; Bereczki D; Kasner SE; Lutsep HL; Tsivgoulis G; Ntaios G; Czlonkowska A; Shuaib A; Amarenco P; Endres M; Diener HC; Gailani D; Kahl A; Donovan M; Perera V; Li D; Hankey GJ
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106742. PubMed ID: 36037679
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.
Heitmeier S; Visser M; Tersteegen A; Dietze-Torres J; Glunz J; Gerdes C; Laux V; Stampfuss J; Roehrig S
J Thromb Haemost; 2022 Jun; 20(6):1400-1411. PubMed ID: 35289054
[TBL] [Abstract][Full Text] [Related]
20. Differential Effect of White-Matter Lesions and Covert Brain Infarcts on the Risk of Ischemic Stroke and Intracerebral Hemorrhage.
Kaffashian S; Tzourio C; Zhu YC; Mazoyer B; Debette S
Stroke; 2016 Jul; 47(7):1923-5. PubMed ID: 27283199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
